Telling the truth about SME life today

Kate Hilyard

Kate Hilyard

Dr Kate Hilyard is Chief Operating Officer at Healx, a technology company from Cambridge University focused on accelerating rare disease treatments by redesigning drug discovery. Healx integrates AI, deep pharmacology expertise, and patient engagement to intelligently match treatments to disease patients. Kate has over 25 years experience in drug discovery working in the pharmaceutical, biotechnology and CRO industries. She has a track record of clear leadership building an integrated world-leading drug discovery organisation with a reputation for quality and delivery, using strong scientific, financial and commercial acumen to ensure a profitable and sustainable business generating growth in value to shareholders. Throughout her career, she has been driven to make a difference to patient lives, from her early academic research in human biology at Oxford and Harvard Universities, to leading drug discovery teams and, ultimately, to leading organisations whose mission is to discover drugs through a sustainable business model. At Healx Kate will be leading the strategy implementation and growth to enable Healx to be able to deliver rare disease treatments at scale.
Only 17% of those working in tech are female. Added to this, a mere 10% hold executive-level positions. How

If you enjoyed this article,
why not join our newsletter?

We promise only quality content, tailored to suit what our readers like to see!